Table 2 Individuals with two intermediate-length alleles in 525 ALS patients and 3950 controls after exclusion of expansion carriers
Shorter/longer allele | Controls n (%) | ALS n (%) | p | OR | 95% CI |
|---|---|---|---|---|---|
≥ 7/≥ 7 | 104 (2.6%) | 26 (5.0%) | 0.005 | 1.93 | 1.19–3.02 |
7–16/7–16 | 94 (2.4%) | 19 (3.6%) | 0.098 | 1.57 | 0.90– 2.62 |
≥ 7/17–45 | 10 (0.25%) | 7 (1.3%) | 0.0020 | 5.32 | 1.71–15.56 |
≥ 7/21–45 | 3 (0.076%) | 6 (1.1%) | 0.00016 | 15.19 | 3.23–94.21 |
≥ 7/24–45 | 1 (0.025%) | 4 (0.76%) | 0.00085 | 30.26 | 2.99–1479 |